Kerala Antibiotics Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 17-12-2024
- Paid Up Capital ₹ 0.47 M
as on 17-12-2024
- Company Age 31 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.28 M
as on 17-12-2024
- Revenue %
(FY 2020)
- Profit 42.44%
(FY 2020)
- Ebitda 42.44%
(FY 2020)
- Net Worth -4.29%
(FY 2020)
- Total Assets %
(FY 2020)
About Kerala Antibiotics
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.47 M.
The company currently has active open charges totaling ₹0.28 M.
Jose Mathew, Mathew Thomas, Issac John, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24231KL1993PTC007218
- Company No.
007218
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 Jul 1993
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Kottayam, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Kerala Antibiotics?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jose Mathew  | Director | 08-Jan-2007 | Current |
| Jose Kurian | Director | 14-Aug-2006 | Current |
| Mathew Thomas | Director | 15-Jul-1993 | Current |
| Issac John | Director | 08-Jan-2007 | Current |
| Rosamma Mathew | Director | 09-Aug-2005 | Current |
Financial Performance of Kerala Antibiotics.
Kerala Antibiotics Pvt Ltd, for the financial year ended 2020, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 42.44% increase in profit. The company's net worth dipped by a decrease of 4.29%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kerala Antibiotics?
In 2020, Kerala Antibiotics had a public holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kokad Pharmaceutical Laboratories LimitedActive 39 years 3 monthsMathew Thomas and Rosamma Mathew are mutual person
Green Shore Holidays And Resorts Private LimitedActive 24 years 3 monthsJose Mathew is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of Travancohe Creation Date: 23 Nov 1995 | ₹0.28 M | Open |
How Many Employees Work at Kerala Antibiotics?
Unlock and access historical data on people associated with Kerala Antibiotics, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kerala Antibiotics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kerala Antibiotics's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
